Re: Conjugated equine estrogen and risk of benign proliferative breast disease: a randomized controlled trial.
Wood
Charles
C
Cline
Mark
M
D000368:Aged; D001941:Breast Diseases / Q000139:chemically induced* / Q000473:pathology*; D001943:Breast Neoplasms / Q000139:chemically induced / Q000473:pathology; D015914:Estrogen Replacement Therapy / Q000009:adverse effects*; D004966:Estrogens, Conjugated (USP) / Q000008:administration & dosage / Q000009:adverse effects*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D006965:Hyperplasia; D008875:Middle Aged; D017698:Postmenopause; D011230:Precancerous Conditions / Q000139:chemically induced* / Q000473:pathology; D016032:Randomized Controlled Trials as Topic; D012107:Research Design
D004966:Estrogens, Conjugated (USP)